axoCellsTM Human iPSC-derived Microglia
Build high-quality neurodegenerative disease models in 7 days.
Ensure confidence in your neural workflow with high-quality axoCellsTM microglia differentiated from human induced pluripotent stem cells (iPSCs). Derived from consenting donor fibroblasts, we’ve specifically designed our production method to equip you with physiologically relevant cells, by mimicking the in vivo pathway of development for brain-resident macrophages.
With Axol, you can rely on physiologically relevant microglia that express the three key markers (IBA1, TMEM119, and P2RY12) and demonstrate robust functional activity, measured by cytokine release, phagocytosis, and chemotaxis. With our microglia, you can build robust mono- and co-culture models to investigate neurological diseases and drug discovery.